Intrahepatic cholangiocarcinoma in the setting of HBV-related cirrhosis: Differentiation with hepatocellular carcinoma by using Intravoxel incoherent motion diffusion-weighted MR imaging

Yi Wei; Feifei Gao; Dandan Zheng; Zixing Huang; Min Wang; Fubi Hu; Chenyang Chen; Ting Duan; Jie Chen; Likun Cao; Bin Song

doi:10.18632/oncotarget.23807

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Intrahepatic cholangiocarcinoma in the setting of HBV-related cirrhosis: Differentiation with hepatocellular carcinoma by using Intravoxel incoherent motion diffusion-weighted MR imaging

Yi Wei _, Feifei Gao, Dandan Zheng, Zixing Huang, Min Wang, Fubi Hu, Chenyang Chen, Ting Duan, Jie Chen, Likun Cao and Bin Song

PDF | HTML | How to cite

Oncotarget. 2018; 9:7975-7983. https://doi.org/10.18632/oncotarget.23807

Metrics: PDF 2048 views | HTML 2456 views | ?

Abstract

Yi Wei1,*, Feifei Gao2,*, Dandan Zheng3, Zixing Huang1, Min Wang1, Fubi Hu1, Chenyang Chen1, Ting Duan1, Jie Chen1, Likun Cao1 and Bin Song1

1Department of Radiology, West China Hospital, Sichuan University, Chengdu, China

2Department of Radiology, Henan Provincial People’s Hospital, Zhengzhou, China

3GE Healthcare China, Beijing, China

*These authors contributed equally to this work

Correspondence to:

Bin Song, email: [email protected]

Keywords: intravoxel incoherent motion; diffusion weighted imaging; hepatocellular carcinoma; intrahepatic cholangiocarcinoma

Received: October 05, 2017 Accepted: November 13, 2017 Published: December 26, 2017

ABSTRACT

Accurate preoperative differentiation of intrahepatic cholangiocarcinoma (ICC) and hepatocellular carcinoma (HCC) in the setting of cirrhotic liver is of great clinical significance because the treatment and prognosis of these entities differ markedly. Through a retrospectively research, we sought to determine the diagnostic performances of intravoxel incoherent motion (IVIM) and diffusion weighted imaging (DWI) parameters in the differentiating of ICC and HCC. According to the results, we found that apparent diffusion coefficient (ADC) derived from mono-exponential model and true ADC (ADC^slow) derived from bi-exponential model can be used to distinguish the ICC and HCC, and ADC^slowentailed the higher diagnostic performance than ADC. However, pseudo-ADC (ADC^fast) and perfusion fraction (f) can not be used to differentiate ICC and HCC. These results suggested that IVIM and DWI parameters can be useful in differentiating ICC and HCC and might be helpful in selecting the treatment plan and predicting prognosis.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23807

Publication Alerts

Research Papers:

Intrahepatic cholangiocarcinoma in the setting of HBV-related cirrhosis: Differentiation with hepatocellular carcinoma by using Intravoxel incoherent motion diffusion-weighted MR imaging

Abstract